Jens D Lundgren
Overview
Explore the profile of Jens D Lundgren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
317
Citations
11992
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raben D, Jakobsen M, Trajanovska J, Kowalska J, Vassilenko A, Dragas S, et al.
PLoS One
. 2025 Jan;
20(1):e0316794.
PMID: 39879174
Many HIV clinics with poor IT-infrastructure are unable to report data on individuals in care with HIV, on antiretroviral treatment (ART) and virologically suppressed (VS), with the aim of monitoring...
2.
Petersen E, Hvid U, Tomori O, Pedersen A, Wallinga J, Pebody R, et al.
Int J Infect Dis
. 2024 Dec;
153():107373.
PMID: 39733916
The recent expansion of mpox in Africa is characterized by a dramatic increase in zoonotic transmission (clade Ia) and the emergence of a new clade Ib that is transmitted from...
3.
Wick K, Siegel L, Oldmixon C, Lundgren J, Thompson B, Jones C, et al.
Am J Physiol Lung Cell Mol Physiol
. 2024 Jul;
327(5):L607-L614.
PMID: 39076084
The soluble receptor for advanced glycation end-products (sRAGE) is a marker of alveolar type I cell injury associated with outcomes in COVID-19 pneumonia. How plasma sRAGE changes over time and...
4.
Reekie J, Stovring H, Nielsen H, Johansen I, Benfield T, Wiese L, et al.
Int J Infect Dis
. 2024 May;
146:107111.
PMID: 38801970
Objectives: This study aimed to compare antibody trajectories among individuals with SARS-CoV-2 hybrid and vaccine-induced immunity. Methods: Danish adults receiving three doses of BTN162b2 or mRNA-1237 were included prior to...
5.
Soborg A, Reekie J, Sengelov H, da Cunha-Bang C, Lund T, Ekenberg C, et al.
Eur J Haematol
. 2024 Jan;
112(5):802-809.
PMID: 38183302
Objectives: Improved survival after hematopoietic cell transplantation (HCT) and an increasingly comorbid transplant population may give rise to new trends in the causes of death. Methods: This study includes all...
6.
Dos Santos Q, Leung P, Thorball C, Ledergerber B, Fellay J, MacPherson C, et al.
Front Mol Biosci
. 2023 Dec;
10:1282412.
PMID: 38131015
Type 2 diabetes mellitus (T2DM) can be multifactorial where both genetics and environmental factors play a role. We aimed to investigate the use of polygenic risk scores (PRS) in the...
7.
Rasmussen K, Dos Santos Q, Macpherson C, Zucco A, Gjaerde L, Ilett E, et al.
Metabolites
. 2023 Sep;
13(9).
PMID: 37755248
Immune dysfunction resulting from allogeneic haematopoietic stem cell transplantation (aHSCT) predisposes one to an elevated risk of cytomegalovirus (CMV) infection. Changes in metabolism have been associated with adverse outcomes, and...
8.
Phillips A, Bansi-Matharu L, Shahmanesh M, Hargreaves J, Smith J, Revill P, et al.
Lancet Glob Health
. 2023 Sep;
11(10):e1648-e1657.
PMID: 37734807
Background: Post-exposure prophylaxis (PEP) offers protection from HIV after condomless sex, but is not widely available in a timely manner in east, central, southern, and west Africa. To inform the...
9.
Zucco A, Bennedbaek M, Ekenberg C, Gabrielaite M, Leung P, Polizzotto M, et al.
AIDS
. 2023 Aug;
37(11):1643-1650.
PMID: 37534724
Objective: Human leucocyte antigen (HLA) class I alleles are the main host genetic factors involved in controlling HIV-1 viral load (VL). Nevertheless, HLA diversity has proven a significant challenge in...
10.
Greenberg L, Ryom L, Bakowska E, Wit F, Bucher H, Braun D, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509301
Despite cancer being a leading comorbidity amongst individuals with HIV, there are limited data assessing cancer trends across different antiretroviral therapy (ART)-eras. We calculated age-standardised cancer incidence rates (IRs) from...